Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.
Chemokine receptors are members of the G protein-coupled receptor (GPCR) family. CCR5 is also the principal co-receptor for macrophage-tropic strains of human immunodeficiency virus, type 1 (HIV-1), and efforts have been made to develop ligands to inhibit HIV-1 infection by promoting CCR5 receptor endocytosis. Given the nature of GPCRs and their propensity to form oligomers, one can consider ligand-based therapies as unselective in terms of the oligomeric composition of complexes. For example, a ligand targeting a CCR5 homomer could likely induce signal transduction on a heteromeric CCR5-CXCR4. Other avenues could therefore be explored. We identified a receptor adaptor interacting specifically with one receptor complex but not others. NHERF1, an adaptor known for its role in desensitization, internalization, and regulation of the ERK signaling cascade for several GPCRs, interacts via its PDZ2 domain with the CCR5 homodimer but not with the CXCR4-CCR5 heterodimer or CXCR4 homodimer. To further characterize this interaction, we also show that NHERF1 increases the CCR5 recruitment of arrestin2 following stimulation. NHERF1 is also involved in CCR5 internalization, as we demonstrate that co-expression of constructs bearing the PDZ2 domain can block CCR5 internalization. We also show that NHERF1 potentiates RANTES (regulated on activation normal T cell expressed and secreted)-induced ERK1/2 phosphorylation via CCR5 activation and that this activation requires NHERF1 but not arrestin2. Taken together, our results suggest that oligomeric receptor complexes can associate specifically with partners and that in this case NHERF1 could represent an interesting new target for the regulation of CCR5 internalization and potentially HIV infection.
Hammad
Maha M
MM
Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 1X5, Canada.
Kuang
Yi-Qun
YQ
Yan
Ronald
R
Allen
Heather
H
Dupré
Denis J
DJ
D002460:Cell Line; D018946:Chemokine CCL5 / Q000235:genetics / Q000378:metabolism; D015658:HIV Infections / Q000235:genetics / Q000378:metabolism*; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D020935:MAP Kinase Signaling System; D019950:Mitogen-Activated Protein Kinase 1 / Q000235:genetics / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000235:genetics / Q000378:metabolism; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation / Q000235:genetics; D055503:Protein Multimerization; D020836:Protein Structure, Quaternary; D017434:Protein Structure, Tertiary; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000235:genetics / Q000378:metabolism*; D017923:Sodium-Hydrogen Exchangers / Q000235:genetics / Q000378:metabolism*
C483024:CCL5 protein, human; C527276:CXCR4 protein, human; D018946:Chemokine CCL5; D010750:Phosphoproteins; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D017923:Sodium-Hydrogen Exchangers; C093376:sodium-hydrogen exchanger regulatory factor; C535150:MAPK1 protein, human; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3
J Cell Sci. 2000 Jun;113 ( Pt 11):1851-6
10806096
Trends Endocrinol Metab. 2006 May-Jun;17(4):159-65
16595179
J Biol Chem. 2004 Dec 24;279(52):54291-303
15452121
Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17705-10
15591354
J Biol Chem. 2007 Dec 14;282(50):36214-22
17884816
J Biol Chem. 2002 Oct 25;277(43):40751-9
12193606
Endocrinology. 2007 Aug;148(8):4073-9
17525124
J Biol Chem. 2000 Aug 11;275(32):25039-45
10859298
J Cell Biol. 1999 Nov 15;147(4):879-90
10562288
J Pept Res. 2005 Mar;65(3):411-7
15787971
J Biol Chem. 2003 Jul 11;278(28):26295-301
12724327
J Biol Chem. 2003 Oct 31;278(44):43787-96
12920119
J Biol Chem. 2002 Jul 26;277(30):27545-52
12004055
Mol Pharmacol. 2007 Dec;72(6):1497-507
17855654
J Virol. 2004 Mar;78(5):2277-87
14963124
Neuron. 2000 Jul;27(1):97-106
10939334
Am J Physiol Renal Physiol. 2001 Mar;280(3):F389-95
11181400
Bioorg Med Chem Lett. 2008 Feb 1;18(3):942-5
18180157
Biochem Biophys Res Commun. 2005 Jun 17;331(4):909-16
15882964
J Clin Invest. 1995 May;95(5):2143-9
7738182
Eur J Biochem. 2004 Jan;271(2):243-52
14717692
J Biol Chem. 2000 Dec 8;275(49):38659-66
10995758
FEBS Lett. 2001 Feb 2;489(2-3):233-6
11165256
Biochemistry. 2001 Jul 24;40(29):8572-80
11456497
Curr Protoc Protein Sci. 2005 Sep;Chapter 19:19.10.1-19.10.21
18429278
J Biol Chem. 1997 Dec 5;272(49):30603-6
9388191
Cell Signal. 2002 Apr;14(4):297-309
11858937
J Am Soc Nephrol. 2004 Sep;15(9):2289-98
15339978
J Biol Chem. 2002 Sep 20;277(38):35402-10
12140284
J Biol Chem. 2000 Sep 1;275(35):27069-74
10852925
Annu Rev Immunol. 1999;17:657-700
10358771
Science. 2000 Mar 3;287(5458):1660-4
10698743
Blood. 2009 Feb 26;113(9):1938-47
19064722
J Cell Biol. 1997 Oct 6;139(1):169-79
9314537
Nature. 1999 Sep 16;401(6750):286-90
10499588
Science. 1997 Jan 3;275(5296):73-7
8974395
J Cell Sci. 2001 Sep;114(Pt 18):3219-31
11591811
Mol Pharmacol. 2009 May;75(5):1189-97
19188335
Nature. 1996 Jun 20;381(6584):661-6
8649511
Mol Cell Biol. 2000 Nov;20(22):8352-63
11046132
Circ Res. 2002 Oct 18;91(8):672-80
12386143
Annu Rev Neurosci. 2001;24:1-29
11283303
Mol Biol Cell. 2008 Apr;19(4):1637-45
18272783
Mol Cell Biol. 2007 Apr;27(7):2527-37
17242191
PLoS One. 2008;3(10):e3424
18923649
J Biol Chem. 2004 Aug 6;279(32):33390-7
15155738
Mol Biol Cell. 2004 Dec;15(12):5470-80
15469991
J Biol Chem. 1998 Jan 16;273(3):1273-6
9430655
Lancet. 2007 Jul 7;370(9581):81-8
17617275
EMBO J. 1997 Aug 1;16(15):4606-16
9303305